Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles

Obstetrics and Gynecology

Volumn 113, Issue 2 PART 1, 2009, Pages 326-331

  Thomas, Chris M G ^a   Kerkmeijer, Linda G W ^b   Massuger, Leon F A G ^b   Ten Kate Booij, Marianne J ^b   Sweep, Fred C G J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b 479 Radboud University Nijmegen Medical Centre ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; MATERNAL AGE; PRIORITY JOURNAL; REGRESSION ANALYSIS; BLOOD; CANCER DIAGNOSIS; COMPARATIVE STUDY; FETUS ECHOGRAPHY; NETHERLANDS; PREGNANCY; REGISTER; THERAPEUTIC ABORTION; UTERUS CANCER;

ABORTION, THERAPEUTIC; CHORIONIC GONADOTROPIN; EARLY DETECTION OF CANCER; FEMALE; GESTATIONAL AGE; HUMANS; HYDATIDIFORM MOLE; NETHERLANDS; PREGNANCY; REGISTRIES; ULTRASONOGRAPHY, PRENATAL; UTERINE NEOPLASMS;

EID: 60549088558     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181945a4f     Document Type: Article

References (19)

1. Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 1995;86:775-9.
2. Jauniaux E, Nicolaides KH. Early ultrasound diagnosis and follow-up of molar pregnancies. Ultrasound Obstet Gynecol 1997;9:17-21.
3. Curry SL, Hammond CB, Tyrey L, Creasman W, Parker RT. Hydatidiform mole: diagnosis, management and long-term follow-up of 347 patients. Obstet Gynecol 1975;45:1-8.
4. Mangili G, Garavaglia E, Cavoretto P, Gentile C, Scarfone G, Rabaiotti E. Clinical presentation of hydatidiform mole in northern Italy: has it changed in the last 20 years? Am J Obstet Gynecol 2008;198:302.e1-4.
5. Niemann I, Petersen LK, Hansen ES, Sunde L. Differences in current clinical features of diploid and triploid hydatidiform mole. BJOG 2007;114:1273-7.
6. Berkowitz R, Ozturk M, Goldstein D, Bernstein M, Hill L, Wands JR. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles. Obstet Gynecol 1989;74:212-6.
7. Van Trommel NE, Sweep FC, Schijf CP, Massuger LF, Thomas CM. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios. Eur J Endocrinol 2005;153:565-75.
8. FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee. Int J Gynecol Obstet 2002;77:285-7.
9. Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E. Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy. Obstet Gynecol 2004;104:551-4.
10. Yedema KA, Verheijen RH, Kenemans P, Schijf CP, Borm GF, Segers MF, et al. Identification of patients with persisten t trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am J Obstet Gynecol 1993; 168:787-92.
11. Dutch Society for Obstetrics and Gynaecology. Richtlijn Basis Prenatale Zorg 1.0 (Guideline basic prenatal care). Available at: http:/www.nvog.nl. Retrieved September 1, 2008.
12. Dutch Society for Obstetrics and Gynaecology. Richtlijn Molazwangerschap 1.2. (Guideline hydatidiform mole). Available at: http://www.nvog.nl. Retrieved September 1, 2008.
13. Sebire NJ, Makrydimas G, Agnantis NJ, Zagorianakou N, Rees H, Fisher RA. Updated diagnostic criteria for partial and complete hydatidiform moles in early pregnancy. Anticancer Res 2003;23:1723-8.
14. Thomas CM, Segers MF, Houx PC. Comparison of the analytical characteristics and clinical usefulness in tumour monitoring of fifteen hCG(-beta) immunoassay kits. Ann Clin Biochem 1985;22:236-46.
15. Mosher R, Goldstein DP, Berkowitz R, Bernstein M, Genest DR. Complete hydatidiform mole. Comparison of clinicopath-ologic features, current and past. J Reprod Med 1998;43:21-7.
16. th Century). Available at: http://www.cbs.nl. Retrieved September 1, 2008.
17. Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Gynecol Oncol 2007;106:142-6.
18. Leopold GR. Diagnostic ultrasound in the detection of molar pregnancy. Radiology 1971;98:171-6.
19. Van Trommel NE, Ngo Duc H, Massuger LF, Schijf CP, Sweep CG, Thomas CM, et al. Early identification of persistent trophoblastic disease with serum hCG concentration ratios. Int J Gynecol Cancer 2008;18:318-23.